Nucleic Acids Research, 1985, Vol. 13, No. 4 1151-1162
© 1985
Articles |
Efficient secretion and purification of human insulin-like growth factor I with a gene fusion vector in Staphylococci
Department of Biochemistry and Biotechnology, Royal Institute of Technology S-100 44 Stockholm 1KabiGen Ltd. S-112 87 Stockholm, sweden 2European Molecular Biology Laboratory Postfach 10.2209, 6900 Heidelberg 1, FRG
To whom correspondence should be addressed
Received December 10, 1984. Revised January 23, 1985. Accepted January 23, 1985.
A novel approach for production of small polypeptides, using a staphylococcal protein A vector, is described. This system is used to express, secrete and purify human insulin-like growth factor I (IGF-I). A fusion protein consisting of protein A and IGF-I is recovered in high yield by passing the culture medium through an IgG affinity column. Using site-specific mutagenesis an acid labile asp-pro cleavage site was introduced at the fusion point between the two proteins. The protein A "tail" can thereby be removed from the affinity purified fusion protein by chemical cleavage releasing biologically active IGF-I molecules.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Leonetti, R. Thai, J. Cotton, S. Leroy, P. Drevet, F. Ducancel, J. C. Boulain, and A. Menez Increasing Immunogenicity of Antigens Fused to Ig-Binding Proteins by Cell Surface Targeting J. Immunol., April 15, 1998; 160(8): 3820 - 3827. [Abstract] [Full Text] [PDF] |
||||
